CHAPTER 1 INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2 RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1. Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3 MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4 MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Rising need for minimally invasive procedures
4.1.2. Shifting the focus of market players on large-bore vascular closure devices
4.1.3. High prevalence of obesity and cardiovascular diseases
4.1.4. Huge number of approvals for vascular closure devices
4.2. Market Restraints & Challenges
4.2.1. High cost & risks associated with vascular closure devices
4.2.2. Product recalls and failures
4.2.3. Increasing preference for interventional procedures using radial artery access
4.2.4. The high requirement of skilled professionals
4.3. Market Opportunities
4.3.1. Increasing research and clinical trials for vascular closure devices
4.3.2. Rising demand for advanced treatment
CHAPTER 5 GLOBAL VASCULAR CLOSURE DEVICES MARKET – BY TYPE
5.1. Passive Approximators
5.2.1. Collagen Plugs
5.2.2. Sealant or Gel-Based Devices
5.2.3. Compression Assist Devices
5.2. Active Approximators
5.2.1. Suture-Based Devices
5.2.2. Clip-Based Devices
5.3. External Hemostatic Devices
CHAPTER 6 GLOBAL VASCULAR CLOSURE DEVICES MARKET – BY ACCESS
6.1. Femoral Access
6.2. Radial Access
CHAPTER 7 GLOBAL VASCULAR CLOSURE DEVICES MARKET – BY PROCEDURE
7.1. Interventional Cardiology
7.2. Interventional Radiology/Vascular Surgery
CHAPTER 8 GLOBAL VASCULAR CLOSURE DEVICES MARKET - BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.2.4. Costa Rica
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Chile
8.3.4. Columbia
8.3.5. Others
8.4. Europe
8.4.1. U.K.
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Netherlands
8.4.8. Switzerland
8.4.9. Poland
8.4.10. Others
8.5. Asia Pacific
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Australia & New Zealand
8.5.6. Malaysia
8.5.7. Singapore
8.5.8. Others
8.6. Middle East & Africa
8.6.1. UAE
8.6.2. Saudi Arabia
8.6.3. Iran
8.6.4. Iraq
8.6.5. Qatar
8.6.6. South Africa
8.6.7. Algeria
8.6.8. Morocco
8.6.9. Nigeria
8.6.10. Egypt
8.6.11. Others
CHAPTER 9 GLOBAL VASCULAR CLOSURE DEVICES MARKET - COMPANY PROFILES
9.1. Cardinal Health, Inc. (Cordis)
9.2. Terumo Corporation
9.3. Abbott Laboratories
9.4. Cardiva Medical, Inc.
9.5. Medtronic PLC
9.6. Morris Innovative, Inc.
9.7. Essential Medical, Inc.
9.8. Merit Medical Systems, Inc.
9.9. Vasorum Ltd.
9.10. TZ Medical, Inc.
9.11. Vivasure Medical Ltd.
9.12. Inseal Medical Ltd.
9.13. Tricol Biomedical, Inc.
9.14. Marine Polymer Technologies
9.15. Advanced Vascular Dynamics
CHAPTER 10 GLOBAL VASCULAR CLOSURE DEVICES MARKET - COMPETITIVE LANDSCAPE
10.1. Market Share Analysis
10.2. Strategies adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 11 MARKET INSIGHTS
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
CHAPTER 12 APPENDIX
12.1. List of Tables
12.2. List of Figures
